High production of IL-12 by human dendritic cells stimulated with combinations of pattern-recognition receptor agonists

• Published in: npj vaccines Vol. 9; no. 1; p. 83
• Main Authors: Gilmour, Brian C., Corthay, Alexandre, Øynebråten, Inger
• Format: Journal Article
• Language: English
• Published: London Nature Publishing Group UK 03.05.2024; Nature Publishing Group; Nature Portfolio
• Subjects: 631/250/262/2106/2108; 631/250/262/2106/2518; 631/250/590/2292; Biomedical and Life Sciences; Biomedicine; Cytokines; Dendritic cells; Infectious Diseases; Ligands; Medical Microbiology; Pattern recognition; Public Health; Vaccine; Vaccines; Virology
• ISSN: 2059-0105; 2059-0105
• DOI: 10.1038/s41541-024-00869-1

The cytokine IL-12p70 is crucial for T helper 1 (Th1) polarization and the generation of type 1 immunity required to fight cancer and pathogens. Therefore, strategies to optimize the production of IL-12p70 by human dendritic cells (DCs) may significantly improve the efficacy of vaccines and immunotherapies. However, the rules governing the production of IL-12p70 remain obscure. Here, we stimulated pattern recognition receptors (PRRs) representing five families of PRRs, to evaluate their ability to elicit high production of IL-12p70 by monocyte-derived DCs. We used ten well-characterized agonists and stimulated DCs in vitro with either single agonists or 27 different combinations. We found that poly(I:C), which engages the RNA-sensing PRRs TLR3 and MDA5, and LPS which stimulates TLR4, were the only agonists that could elicit notable IL-12p70 production when used as single ligands. We identified six different combinations of PRR agonists, all containing either the TLR3/MDA5 agonist poly(I:C) or the TLR7/8 agonist R848, that could synergize to elicit high production of IL-12p70 by human DCs. Five of the six combinations also triggered high production of the antiviral and antitumor cytokine IFNβ. Overall, the tested PRR ligands could be divided into three groups depending on whether they triggered production of both IL-12p70 and IFNβ, only one of the two, or neither. Thus, combinations of PRR agonists were found to increase the production of IL-12p70 by human DCs in a synergistic manner, and we identified six PRR agonist combinations that may represent strong adjuvant candidates, in particular for therapeutic cancer vaccines.